Drugs / AL0206st
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00818181 | Jun 2008 → Feb 2009 | allergic rhinitis | Allergopharma GmbH & Co. KG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL0206st | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00818181 ↗ |
| Modality | Other / unclassified | “Solution of birch pollen allergen extract” NCT00818181 ↗ |
| Route | Other | “administered under the tongue” NCT00818181 ↗ |